Justices Told Horizon's IP Loss 'Casts A Pall' On 32K Patents

Law360 (July 30, 2020, 9:47 PM EDT) -- Horizon is urging the U.S. Supreme Court to take up its appeal of a divided Federal Circuit decision that struck down part of its patented arthritis drug Pennsaid, saying the ruling "casts a pall of uncertainty" over the validity of tens of thousands of patents with similar phrasing.

In a July 24 petition for a writ of certiorari docketed Wednesday, Horizon told the justices that the Federal Circuit erred in upholding a New Jersey federal court's decision that several claims in Horizon's patents for Pennsaid were invalid for being indefinite. The appeals court had ruled that when a patent claim uses the phrase "consisting...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!